These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 21352639

  • 21. Azelastine and olopatadine in the treatment of allergic rhinitis.
    Kaliner MA.
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
    [Abstract] [Full Text] [Related]

  • 22. Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.
    Roland PS, Ryan MW, Wall GM.
    Expert Opin Pharmacother; 2010 Jun; 11(9):1559-67. PubMed ID: 20482305
    [Abstract] [Full Text] [Related]

  • 23. Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study.
    Fifer S, Toh L, Barkate H, Aggarwal V, Borade D, Gordonsmith RH, Wu W, Morgan C, Young K.
    Patient Prefer Adherence; 2023 Jun; 17():141-151. PubMed ID: 36687019
    [Abstract] [Full Text] [Related]

  • 24. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 25. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment.
    Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, Philpot EE.
    Allergy Asthma Proc; 2009 Sep; 30(2):120-7. PubMed ID: 19463202
    [Abstract] [Full Text] [Related]

  • 26. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W.
    Allergy Asthma Proc; 2012 Sep; 33(4):324-32. PubMed ID: 22856633
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
    Patel P, Salapatek AM, Talluri RS, Tantry SK.
    Allergy Asthma Proc; 2018 May 01; 39(3):224-231. PubMed ID: 29669667
    [Abstract] [Full Text] [Related]

  • 28. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N, Wober W, Rahlfs VW, Baehre M.
    Arzneimittelforschung; 2001 May 01; 51(5):387-93. PubMed ID: 11413739
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
    Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H.
    Allergy Asthma Proc; 2009 May 01; 30(6):628-33. PubMed ID: 19930788
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
    Howland WC, Amar NJ, Wheeler W, Sacks H.
    Int Forum Allergy Rhinol; 2011 May 01; 1(4):275-9. PubMed ID: 22287431
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, Khanova FM.
    Int Arch Allergy Immunol; 2019 May 01; 178(3):255-263. PubMed ID: 30677766
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug 01; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 33. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
    Hampel FC, Pedinoff AJ, Jacobs RL, Caracta CF, Tantry SK.
    Allergy Asthma Proc; 2019 Jul 03; 40(4):261-272. PubMed ID: 31053180
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
    van Bavel J, Howland WC, Amar NJ, Wheeler W, Sacks H.
    Allergy Asthma Proc; 2009 Jul 03; 30(5):512-8. PubMed ID: 19747429
    [Abstract] [Full Text] [Related]

  • 35. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis.
    Han D, Chen L, Cheng L, Liu S, Fu Z, Zhang W, Wang C, Xi L, Zhang L, Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G).
    ORL J Otorhinolaryngol Relat Spec; 2011 Jul 03; 73(5):260-5. PubMed ID: 21832863
    [Abstract] [Full Text] [Related]

  • 36. Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study.
    Duarte C, Baëhre M, Gharakhanian S, Leynadier F, French Azelastine Study Group.
    J Investig Allergol Clin Immunol; 2001 Jul 03; 11(1):34-40. PubMed ID: 11436969
    [Abstract] [Full Text] [Related]

  • 37. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis.
    Kortekaas Krohn I, Callebaut I, Alpizar YA, Steelant B, Van Gerven L, Skov PS, Kasran A, Talavera K, Wouters MM, Ceuppens JL, Seys SF, Hellings PW.
    Allergy; 2018 May 03; 73(5):1084-1093. PubMed ID: 29121401
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W, Diez Crespo CD, Bähre M.
    Arzneimittelforschung; 1997 Jul 03; 47(7):841-4. PubMed ID: 9272242
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Yamamoto H, Yamada T, Kubo S, Osawa Y, Kimura Y, Oh M, Susuki D, Takabayashi T, Okamoto M, Fujieda S.
    Allergy Asthma Proc; 2010 Jul 03; 31(4):296-303. PubMed ID: 20819319
    [Abstract] [Full Text] [Related]

  • 40. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
    Lieberman PL, Settipane RA.
    Allergy Asthma Proc; 2003 Jul 03; 24(2):95-105. PubMed ID: 12776442
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.